PUBLICATIONS
Publications
Advancing bronchiectasis care: from innovative treatments to global insights
We aim to make the results of our research free and accessible to all. You can find links to EMBARC publications below:
EMBARCing on a new era for bronchiectasis: a review series for the Seventh World Bronchiectasis Conference
Chalmers, J.D., Goeminne, P.C., Ringshausen, F.C. Eur Respir Rev, 2024
Read Full Text
Airway clearance management in people with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)
Spinou, A., Hererro-Cortina, B., Aliberti, S., et al. Eur Respir J, 2024
Diagnostic delay and access to care in bronchiectasis: data from the EMBARC/ELF patient survey
Spinou, A., Almagro, M., Harris, B., et al. Eur Respir J, 2024
Endotypes of exacerbation in bronchiectasis: an observational cohort study
Gao, Y., Richardson, H., Dicker, A.J., et al. Am J Respir Crit Care Med, 2024
Sputum metagenomics of people with bronchiectasis
Rosenboom, I., Thavarasa, A., Richardson, H., et al. ERJ Open Res, 2024
Eradication treatment for Pseudomonas aeruginosa infection in adults with bronchiectasis: a systematic review and meta-analysis
Conceição, M., Shteinberg, M., Goeminne, P., et al. Eur Respir Rev, 2024
Prescribing preferences and availability of nebulisers and inhalers for inhaled medications in bronchiectasis: results of a specialist survey
Shteinberg, M., Spinou, A., Goeminne, P., et al. ERJ Open Res, 2024
Bronchiectasis and asthma: Data from the European Bronchiectasis Registry (EMBARC)
Polverino, E., Dimakou, K., Traversi, L., et al. J Allergy Clin Immunol, 2024
The Association Between Bronchiectasis and Chronic Obstructive Pulmonary Disease: Data from the European Bronchiectasis Registry (EMBARC)
Polverino, E., De Soyza, A., Dimakou, K., et al. Am J Respir Crit Care Med, 2024
Structural Lung Disease and Clinical Phenotype in Bronchiectasis Patients: The EMBARC CT Study
Pieters, A. L. P., van der Veer, T., Meerburg, J. J., et al. Am J Respir Crit Care Med, 2024
Objective sputum colour assessment and clinical outcomes in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)
Aliberti, S., Ringshausen, F. C., Dhar, R., et al. Eur Respir J, 2024
Clinical outcomes of bronchiectasis in India: data from the EMBARC/Respiratory Research Network of India registry
Dhar, R., Singh, S., Talwar, D., et al. Eur Respir J, 2023
Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)
Chalmers, J. D., Polverino, E., Crichton, M. L., et al. Lancet Respir Med, 2023
Transforming clinical research and science in bronchiectasis: EMBARC3, a European Respiratory Society Clinical Research Collaboration
Chalmers, J.D., Aliberti, S., Altenburg, J., et al. Eur Respir J, 2023
A Phase 2 randomised study to establish efficacy, safety and dosing of a novel oral cathepsin C inhibitor, BI 1291583, in adults with bronchiectasis: Airleaf
Chalmers, J.D., Gupta, A., Chotirmall, S.H., et al. ERJ Open Res, 2023
Airway clearance treatments in bronchiectasis: feasibility of linking survey results to registry data and a survey of patients’ and physiotherapists’ practices
McLeese, R.H., O’Neill, K., O’Neill, B., et al. ERJ Open Res, 2023
Inflammatory molecular endotypes in bronchiectasis: a European multicenter cohort study
Choi, H., Ryu, S., Keir, H.R., et al. Am J Respir Crit Care Med, 2023
Read Full Text
Intermittent prophylactic antibiotics for bronchiectasis
Spencer, S., Donovan, T., Chalmers, J.D., et al. Cochrane Database Syst Rev, 2022
ROSE: radiology, obstruction, symptoms and exposure – a Delphi consensus definition of the association of COPD and bronchiectasis by the EMBARC Airways Working Group
Traversi, L., Miravitlles, M., Martinez-Garcia, M. A., et al. ERJ Open Res, 2021
What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey
Shteinberg, M., Boyd, J., Aliberti, S., et al. ERJ Open Res, 2021
Patients’ perspectives on bronchiectasis: findings from a social media listening study
Delestre-Levai, I., Aliberti, S., Almagro, M., et al. ERJ Open Res, 2021
Read Full Text
Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study
Keir, H.R., Shoemark, A., Dicker, A.J., et al. Lancet Respir Med, 2021
Read Full Text
Recommendations for travelling with bronchiectasis: a joint ELF/EMBARC/ERN-Lung collaboration
Shteinberg, M., Crossley, B., Lavie, T., et al. ERJ Open Res, 2019
Bronchiectasis in India: results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry
Dhar, R., Singh, S., Talwar, D., et al. Lancet Glob Health, 2019
Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis Network
Chalmers, J. D., Ringshausen, F. C., Harris, B., et al. Eur Respir J, 2018
The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) ERS Clinical Research Collaboration
Aliberti, S., Polverino, E., Chalmers, J. D., et al. Eur Respir J, 2018
The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions
Polverino, E., Dimakou, K., Hurst, J., et al. Eur Respir J, 2018
Read Full Text
Continuous versus intermittent antibiotics for bronchiectasis
Donovan, T., Felix, L.M., Chalmers, J.D., et al. Cochrane Database Syst Rev, 2018
Read Full Text
Patient participation in ERS guidelines and research projects: the EMBARC experience
Chalmers, J. D., Timothy, A., Polverino, E., et al. Breathe (Sheff), 2017
The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC): experiences from a successful ERS Clinical Research Collaboration
Chalmers, J. D., Crichton, M., Goeminne, P. C., et al. Breathe (Sheff), 2017
European Respiratory Society guidelines for the management of adult bronchiectasis
Polverino, E., Goeminne, P.C., McDonnell, M.J., et al. Eur Respir J, 2017
Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research
Hill, A.T., Haworth, C.S., Aliberti, S., et al. Eur Respir J, 2017
The EMBARC European Bronchiectasis Registry: protocol for an international observational study
Chalmers, J. D., Aliberti, S., Polverino, E., et al. ERJ Open Res, 2016
Research priorities in bronchiectasis: a consensus statement from the EMBARC Clinical Research Collaboration
Aliberti, S., Masefield, S., Polverino, E., et al. Eur Respir J, 2016
Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study
McDonnell, M.J., Aliberti, S., Goeminne, P.C., et al. Lancet Respir Med, 2016
COPD and bronchiectasis: phenotype, endotype or co-morbidity?
Blasi, F., Chalmers, J.D., Aliberti, S. COPD, 2014